Cargando…
Hurdles to uptake of mesenchymal stem cells and their progenitors in therapeutic products
Twenty-five years have passed since the first clinical trial utilising mesenchymal stomal/stem cells (MSCs) in 1995. In this time academic research has grown our understanding of MSC biochemistry and our ability to manipulate these cells in vitro using chemical, biomaterial, and mechanical methods....
Autores principales: | Childs, Peter G., Reid, Stuart, Salmeron-Sanchez, Manuel, Dalby, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505558/ https://www.ncbi.nlm.nih.gov/pubmed/32941644 http://dx.doi.org/10.1042/BCJ20190382 |
Ejemplares similares
-
Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases
por: Wang, Yu, et al.
Publicado: (2020) -
Pluripotent Stem Cell‐Derived Hematopoietic Progenitors Are Unable to Downregulate Key Epithelial‐Mesenchymal Transition‐Associated miRNAs
por: Meader, Ellie, et al.
Publicado: (2017) -
Bovine tongue epithelium-derived cells: A new source of bovine mesenchymal stem cells
por: Lee, Jienny, et al.
Publicado: (2020) -
BMP9 exhibits dual and coupled roles in inducing osteogenic and angiogenic differentiation of mesenchymal stem cells
por: Xiao, Haozhuo, et al.
Publicado: (2020) -
MiR-128 promotes osteogenic differentiation of bone marrow mesenchymal stem cells in rat by targeting DKK2
por: Wang, Can, et al.
Publicado: (2020)